Spero Therapeutics Inc (SPRO)
1.175
-0.08
(-6.00%)
USD |
NASDAQ |
Nov 15, 16:00
1.175
0.00 (0.00%)
After-Hours: 17:39
Spero Therapeutics Net Income (TTM): 17.46M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.46M |
| March 31, 2024 | 23.40M |
| December 31, 2023 | 22.81M |
| September 30, 2023 | -1.614M |
| June 30, 2023 | -10.08M |
| March 31, 2023 | -26.85M |
| December 31, 2022 | -46.42M |
| September 30, 2022 | -102.43M |
| June 30, 2022 | -113.27M |
| March 31, 2022 | -103.16M |
| December 31, 2021 | -89.76M |
| September 30, 2021 | -79.10M |
| June 30, 2021 | -75.52M |
| March 31, 2021 | -74.44M |
| December 31, 2020 | -78.28M |
| Date | Value |
|---|---|
| September 30, 2020 | -84.68M |
| June 30, 2020 | -83.46M |
| March 31, 2020 | -79.11M |
| December 31, 2019 | -60.92M |
| September 30, 2019 | -46.54M |
| June 30, 2019 | -39.28M |
| March 31, 2019 | -36.09M |
| December 31, 2018 | -41.66M |
| September 30, 2018 | -44.92M |
| June 30, 2018 | -44.30M |
| March 31, 2018 | -43.51M |
| December 31, 2017 | -38.74M |
| September 30, 2017 | -32.09M |
| June 30, 2017 | -28.57M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-113.27M
Minimum
Jun 2022
23.40M
Maximum
Mar 2024
-55.02M
Average
-75.52M
Median
Jun 2021
Net Income (TTM) Benchmarks
| Arbutus Biopharma Corp | -76.70M |
| Equillium Inc | -8.318M |
| NovaBay Pharmaceuticals Inc | -10.12M |
| Palatin Technologies Inc | -30.42M |
| iBio Inc | -24.91M |